DiaMedica Therapeutics Inc.
DMAC
$5.42
-$0.19-3.39%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 2.50M | 2.51M | 2.60M | 2.19M | 2.49M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.48M | 9.21M | 9.03M | 8.01M | 8.14M |
| Operating Income | -10.48M | -9.21M | -9.03M | -8.01M | -8.14M |
| Income Before Tax | -10.04M | -8.73M | -8.61M | -7.69M | -7.70M |
| Income Tax Expenses | 7.00K | 10.00K | 6.00K | 6.00K | 6.00K |
| Earnings from Continuing Operations | -10.04M | -8.74M | -8.62M | -7.70M | -7.71M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.04M | -8.74M | -8.62M | -7.70M | -7.71M |
| EBIT | -10.48M | -9.21M | -9.03M | -8.01M | -8.14M |
| EBITDA | -10.47M | -9.20M | -9.02M | -8.00M | -8.13M |
| EPS Basic | -0.19 | -0.17 | -0.17 | -0.18 | -0.18 |
| Normalized Basic EPS | -0.12 | -0.10 | -0.11 | -0.11 | -0.11 |
| EPS Diluted | -0.19 | -0.17 | -0.17 | -0.18 | -0.18 |
| Normalized Diluted EPS | -0.12 | -0.10 | -0.11 | -0.11 | -0.11 |
| Average Basic Shares Outstanding | 53.79M | 52.42M | 49.63M | 42.96M | 42.84M |
| Average Diluted Shares Outstanding | 53.79M | 52.42M | 49.63M | 42.96M | 42.84M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |